Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial

• المؤلفون الرئيسيون: Yongliang Feng (مؤلف), Xiaohong Shi (مؤلف), Jing Shi (مؤلف), Linying Gao (مؤلف), Guangming Liu (مؤلف), Yanpeng Cheng (مؤلف), Minghu Pan (مؤلف), Chunxia Li (مؤلف), Jun Wang (مؤلف), Xuxia Guo (مؤلف), Yawei Zhang (مؤلف), Xiaofeng Liang (مؤلف), Suping Wang (مؤلف)
• التنسيق: كتاب
• منشور في: Taylor & Francis Group, 2017-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: To evaluate the immunogenicity, antibody persistence, and safety of the 60 µg hepatitis B vaccine in hemodialysis patients in China. Methods: We conducted a multicenter, randomized, double-blind, parallel-controlled trial including 352 hemodialysis patients who were centrally randomized...